Killer Patents
|
|
In the computer technology business, we tend to see patents as being bad for developers and business. What we don't realize that the problems we have with Microsoft's bogus patent claims against Linux and Oracle's patent-based attack against Google are nothing compared to the evils that IP patents bring to the pharmacy business. Take, for example, the assault that the Public Patent Foundation (PUBPAT) is now mounting on Abbot Labs. PUBPAT is formally asking the United States Patent and Trademark Office to reexamine eight Abbot patents relating to the critical HIV/AIDS drug Ritonavir, aka Norvir.
|
|
Full Story |
This topic does not have any threads posted yet!
You cannot post until you login.
